Applied dna announces second quarter fiscal year 2024 financial results

Stony brook, ny / accesswire / may 10, 2024 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced consolidated financial results for its second fiscal quarter ended march 31, 2024. the company's form 10-q can be viewed at https://investors.adnas.com/sec-filings/.

APDN Ratings Summary

APDN Quant Ranking